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ABSTRACT
Cloned lines of Adriamycin (ADR)-sensitive and -resistant P388 leu
kemia have been established, including P388/ADR/3 and P388/ADR/7
that are 5- and 10-fold more resistant than the cloned sensitive cell line
P388/4 (Cancer Res., 46: 2978, 1986). A time course of ADR-induced
DNA double-strand breaks revealed that in sensitive P388/4 cells, evi
dence of DNA repair was noted 4 h after removal of drug, whereas in
resistant clone 3 and 7 cells repair was observed l h after drug removal.
The earlier onset of DNA repair was statistically significant (p = 0.0154
for clone 3 cells, and p = 0.0009 for clone 7 cells). By contrast, once the
repair process was initiated, the rate of repair was similar for all three
cell lines.
The level of glutathione transferase activity was determined in whole
cell extracts. Enzyme activity (mean Â±SE) in sensitive cells was 9.49 Â±
1.00 nmol/min/mg protein, that in resistant clone 3 cells was 13.36 Â±
1.03 nmol/min/mg, and that in clone 7 cells was 13.96 Â±1.44nmol/min/
my; the 1.44-fold increase in enzyme activity in resistant cells was
statistically significant (/> = 0.01). Further evidence of induction of
glutathione transferase was provided by Northern blot analysis using a
"P-labeled cDNA for an anionic glutathione transferase, which demon
strated approximately a twofold increase in mRNA in resistant clone 7
cells. Western blot analysis with a polyvalent antibody against anionic
glutathione transferase also revealed a proportionate increase in gene
product in resistant cells.
Dose-survival studies showed that ADR-resistant cells were cross-
resistant to actinomycin D, daunorubicin, mitoxantrone, colchicine, and
etoposide, but not to the alkylating agent melphalan; this finding provided
evidence that these cells are multidrug resistant. Using a cDNA probe
for P-glycoprotein, a phenotypic marker for multidrug resistance, North
ern blot analysis showed an ineÂ«:ase in the steady state level of mRNA
of approximately twofold in resistant clone 3 and 7 cells. Southern
analysis with the same cDNA probe showed no evidence of gene ampli
fication or rearrangement. Western blot analysis with monoclonal C219
antibody demonstrated a distinct increase in P-glycoprotein in resistant
cells.
Efflux of Adriamycin as measured by the efflux rate constant was
identical in all three cell lines. Furthermore, the metabolic inhibitors
azide and dinitrophenol did not augment drug uptake in either sensitive
or resistant cells. These findings suggest that despite the increase in P-
glycoprotein, an active extrusion pump was not operational in these cells.
This and previous studies provide unequivocal evidence that resistance
to Adriamycin is multifactorial. Decreased drug uptake, decreased for
mation of DNA single- and double-strand breaks, increased glutathione
transferase activity, earlier onset of DNA repair, as well as elevated
P-glycoprotein are all characteristic of multifactorial drug resistance.
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INTRODUCTION
Resistance to ADR4 has been attributed to the presence of an
energy-dependent active extrusion pump in heterogeneous pop
ulations of ADR-resistant P388 leukemic cells (1-3) and in
other anthracycline-resistant cells (4-5). In cloned P388 leu
kemic cells, resistance to ADR was found to be multifactorial;
reduced drug uptake as well as reduced susceptibility of cells to
DNA single- and double-strand breaks was observed in resistant
cells (6).
GST has also been implicated in resistance of tumor cells to
chemotherapeutic agents (7, 8). Elevation of an anionic GST
has been reported in human MCF-7 breast cancer cells resistant
to ADR (7), and human SCC-25 squamous carcinoma cells
resistant to cis-diamminedichloroplatinum(II) (9). By conjugat
ing glutathione with various xenobiotics, GST may play a role
in the mechanism of resistance to antitumor agents (7-9).
Resistance to ADR is also associated with MDR or pleio-
tropic drug resistance (10-13). The MDR phenotype may ap
pear as a result of amplification of the mar or gpl 70 gene (14,
15), which encodes for a plasma membrane glycoprotein of M,
170,000 called P-glycoprotein. The MDR phenotype may also
be found without evidence of gene amplification but with over-
expression of mRNA of the mdr gene (14). Using DNA trans-
fection experiments, it has been shown that a full length cDNA
clone from MDR cells confers multidrug resistance on drug-
sensitive cells (14). P-Glycoprotein apparently acts to facilitate
drug efflux from cells (16) and a striking homology has been
reported between P-glycoprotein and a bacterial hemolysin
transport protein ( 17).
In this report, further evidence is provided in support of the
proposition that resistance to ADR in cloned P388 leukemic
cells is multifactorial. Evidence is also provided to indicate that
increase in expression of the P-glycoprotein gene without evi
dence of gene amplification or rearrangement is associated with
the MDR phenotype expressed in these cells. However, altera
tion of drug efflux could not be demonstrated in resistant cells,
using two independent tests of drug efflux. The significance of
these findings is discussed relative to the role of P-glycoprotein
in multifactorial drug resistance.
MATERIALS AND METHODS
Cell Lines and Cultures. Cloned lines of ADR-sensitive and -resistant
P388 leukemia cells have been established previously (6); the cloned
sensitive line was designated P388/4 whereas the cloned resistant lines
were designated P388/ADR/3 (clone 3) and P388/ADR/7 (clone 7).
The cell lines were maintained in vivo by weekly transplantation of an
4 The abbreviations used are: ADR, Adriamycin; GST, glutathione .Vtransfer
ase; MDR, multidrug resistance; SDS-PAGE, sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis; DSB, double-strand breaks; CHO, Chinese hamster
ovary; SSC, standard saline citrate (0.15 M sodium chloride:0.015 M sodium
citrate, pH 7.4).
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inoculum of IO6cells i.p. in 6-8-week-old female DBA/2 mice. Suspen
sion cultures in vitro were maintained by growing the cells in RPMI
medium supplemented with 15% fetal bovine serum (GIBCO, Grand
Island, NY). Cells used in all the experiments grew exponentially with
a doubling time of 11 to 12 h.
Drugs and Chemicals. [14C]ADRlabeled at the 14-C position (specific
activity, 28 mCi/mmol) was synthesized by M. Leaffer of the Stanford
Research Institute, Menlo Park, CA and was kindly provided by Dr.
Robert R. Engle, Developmental Therapeutics Program, Division of
Cancer Treatment, National Cancer Institute, Bethesda, MD. The
radiochemical purity was 98% as determined by thin-layer chroma-
tography on silica gel in chloroform:methanol:acetic acid:water
(40:10:3:1). Nonradioactive ADR was obtained from Adria Laborato
ries, Columbus, OH. [l4C]Thymidine (specific activity, 50 mCi/mmol)
and [3H]thymidine (specific activity, 50-80 Ci/mmol) were obtained
from New England Nuclear, Boston, MA. Nonradioactive thymidine,
glutathione, and l-chloro-2,4-dinitrobenzene were purchased from
Sigma Chemical Co., St. Louis, MO. Proteinase K was purchased from
E. Merck, Damstadt, Germany, and tetrapropylammonium hydroxide
was from the Eastman Kodak Company, Rochester, NY.
Drug Efflux Studies. Efflux studies were performed in suspension
cultures incubated in vitro at cell concentrations of 2 to 4 x 1(1''cells/
ml in Dulbecco's phosphate buffered saline. Cells were loaded with
[14C]ADR by incubation for 10 min at 37Â°C.Incubations were termi
nated by rapid chilling to 4"C and the cell suspension centrifugea
through a layer of SF120 oil in Hopkin's vaccine tubes to remove
extracellular radioactivity. Washed cells were resuspended at 37Â°Cin a
sufficient volume of prewarmed Dubecco's phosphate-buffered saline
to minimize the problem of drug reentry; aliquots were removed,
chilled, and centrifuged through SF120 oil in Eppendorf tubes, the cells
were solubilized in 0.5 N NaOH, and radioactivity was determined by
liquid scintillation spectrometry. Cell aliquots were removed prior to
efflux in order to obtain the initial intracellular concentration of labelled
drug. [ ' 11|in ulin was used as a marker of extracellular water to correct
for extracellular drug carried through the oil with the cells. The first-
order rate constant (K) for ADR efflux was obtained by linear regression
analysis of a semilogarithmic plot of a time course of drug efflux over5 min (18, 19). A' is equal to the negative slope of the linear regression
line; the half time (7".Jof ADR efflux was calculated using the equation
TV,= In 2/K.
Estimation of DNA Double-Strand Breaks by Neutral Elution. To
determine the time course of repair of DNA double-strand breaks, cells
prelabeled with [MC]thymidine were treated with Adriamycin for l h in
RPMI medium without serum and then incubated at 37Â°Cfor 24 h in
RPMI containing 15% fetal bovine serum; aliquots of the cell suspen
sion were taken at various time points following drug treatment to
determine the number of DNA double-strand breaks.
To determine DNA double-strand breaks, 1 x IO6drug treated cells
labeled with [14C]thymidine were combined with an internal standard,
consisting of 1 x K)6 cells labeled with [3H]thymidine and irradiated
with 3000 rads. The combined cell suspension was placed on a 2.0 ^m
polycarbonate filter (Nucleopore Corp.) and lysed for l h with a solution
containing 0.5 mg/ml proteinase K. DNA double-strand breaks were
detected by the neutral elution technique using a buffer consisting of
0.02 M EDTA and a sufficient quantity of 10% tetrapropylammonium
hydroxide to give a final pH of 9.6 as described previously (20). Elution
of [I4C]DNA was plotted against the simultaneous elution of [3H]DNA
as described previously (21, 22). The rate of elution of DNA, which is
a function of the number of DNA double-strand breaks, was converted
into rad equivalents using standard calibration curves obtained by
treating each cell line with a dose range of radiation. The concentration
of drug used for treatment of each cell line was selected to reduce the
surviving cell fraction to between 0.1 and 0.15, as previously determined
by clonogenic assay (6).
Assay of Cytotoxic Activity. The sensitivity of drug-sensitive and
-resistant cells to a variety of chemotherapeutic drugs was determined
by the clonogenic assay of Chu and Fisher (23). Exponential phase cells
at a concentration of 2 to 3 x 10s cells/ml were treated with drug for 1
h at 37Â°Cin RPMI 1640 medium. The cloning efficiency of treated
cells was determined at each drug concentration and surviving cell
fraction was calculated. Linear regression analysis of the dose-survival
curves was performed, the regression equation being in the form logey
= mx + b where y is surviving cell fraction, x is dose of drug, m is slope
of the regression line, and h is the ^-intercept. Do, the dose of drug
reducing survival to l/e, i.e., 37% of the initial cell population, was
derived from the negative reciprocal of the slope of the regression line
as described previously (24-26).
Glutathione-5-Transferase Assay. Glutathione-S-transferase enzyme
activity was measured according to the method described by Habig et
al. (27). Exponentially growing cells were lysed by sonication three
times for 10 s in distilled water. The cell lysate was centrifuged at
10,000 rpin for 15 min and the supernatant used for the enzyme assay.
To a 1-ml cuvette was added 0.1 ml of 10 mM GSH in l M KPO< (pH
6.5), 20 Â¿ilof 50 HIM l-chloro-2,4-dinitrobenzene in absolute ethanol,
and the appropriate amount of sample (as g protein); distilled water
was then added to make up the volume to 1 ml. The absorbance at 340
nm was recorded for 5 min at 25Â°Cin a DU-8 spectrophotometer.
Enzyme activity was calculated in nmol/min/mg protein or nmol/min/
cell.
Drug Uptake Studies. Drug uptake studies were performed as de
scribed previously (28, 29) by addition of [I4C]ADR to drug-sensitive
and -resistant P388 leukemia cells suspended in Dulbecco's phosphate-
buffered saline. Incubations were terminated by rapid chilling to 4Â°C
and centrifugation through a layer of SF120 oil in Eppendorf tubes.
The washed cells were solubilized in 0.5 N NaOH and radioactivity was
determined by liquid scintillation spectrometry.
RNA Extraction and Northern Blot Analysis. RNA was isolated from
logarithmically growing cultured cells by the guanidinium isothiocya-
nate method (30). Poly(A)+ RNA was extracted after two cycles of
absorption and elution from an oligodeoxythymidylate-cellulose col
umn (31). Five fig of each mRNA preparation was size fractionated in
a 1% formaldehyde-agarose gel and transferred onto nitrocellulose
(Schleicher and Schnell. Inc., Keene, NH). The filter was prehybridized
at 42Â°Cin 50% formamide, 5x Denhardt's reagent, 5x SSPE (1 x
SSPE is 0.15 M NaCl, 0.01 M sodium phosphate, and 0.001 M EDTA)
and 100 Â¿igml" ' denatured salmon sperm DNA. Hybridization was
performed overnight in the same solution containing 10'' cpm of either
an EcoRl-generated 640-base pair pCHPl insert or a 332-base pair
fragment of plasmid PTSS 1-2 that contains nucleotides 110 to 436 of
the cDNA sequence for human GS'IV. After hybridization, the filter
was washed in 2x SSC (Ix SSC is 0.15 M NaCl and 0.015 M sodium
citrate) and 0.1% SDS (sodium dodecyl sulfate) with a final wash in
O.lx SSC and 0.1% SDS at 60Â°C.Autoradiograms were obtained at
-70Â°C on Kodak XAR film with DuPont Cronex Lightning-Plus
screens.
DNA Isolation and Southern Blot Analysis. Genomic DNA from
cultured cells was prepared by phenol-chloroform extraction (32). After
digestion with EcoR 1,1'st 1, or Hindlll (Boehringer-Mannheim, FRG),
equivalent amounts of DNA were electrophoresed in 0.7% agarose gel
and blotted onto nitrocellulose. Hybridization conditions were as de
scribed above.
Isolation of Membrane Proteins and Western Blot Analysis. Cells
were homogenized by sonication and plasma membrane fractions were
isolated by ultracentrifugation as described previously (33). Protein was
assayed by the method of Lowry et al. (34). Membrane protein, 50 /ig
per lane, was resolved by SDS-PAGE using the method of Debenham
et al. (35) and transferred to nitrocellulose by the method of Towbin et
al. (36). The blots were incubated at 37Â°Covernight in blocking buffer
(3% bovine serum albumin, 10.5 HIM Tris hydrochloride at pH 7.4,
0.175 M NaCl and 15 HIMsodium azide) followed by incubation with
C219 monoclonal antibody in fresh blocking buffer at 4Â°Cfor 16 h.
The filters were washed with Tris-saline buffer, incubated with alkaline-
phosphatase conjugated goat anti-mouse IgG in blocking buffer at room
temperature, rewashed with Tris-saline buffer and developed using
substrate for alkaline phosphatase as described by the supplier (Be
thesda Research Lab, Gaithersburg, MD).
Isolation of Cytosolic Proteins and Western Blot Analysis. Exponen
tially growing cells were sonicated and centrifuged at 11,000 x g for 20
min at 4Â°C.The supernatant was ultracentrifuged at 105,000 x g for 1
h at 4"C and 100 /ig of the cytosolic protein was separated by 12%
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sodium dodecyl sulfate-polyacrylamide gel electrophoresis by the
method of Laemmli (37) and transferred by electroblotting to nitrocel
lulose (36). The nitrocellulose sheet was blocked with 3% bovine serum
albumin/0.05% Tween 80 in phosphate-buffered saline, followed by
incubation with rabbit-anti-human GSTV and subsequently alkaline
phosphatase conjugated goat anti-rabbit antibody. After further wash
ing, the blot was developed as described above.
RESULTS
Cytotoxic Activity of Various Chemotherapeutic Agents
against Adriamycin-sensitive and -resistant P388 Leukemic
Cells. Dose-survival curves of ADR-sensitive and -resistant
P388 leukemic cells were determined following treatment with
a variety of Chemotherapeutic agents (Table 1). At least a 50-
fold variation was noted in the Do for sensitive P388/4 cells
ranging approximately from a A>of 9 to 13 nM for daunorubicin
and actinomycin D, respectively, the most potent agents, to a
Do of 601 nM for etoposide and of 684 nM for melphalan, the
least active compounds. P388/ADR/3 cells were 5-fold more
resistant and P388/ADR/7 cells 10-fold more resistant to Adri-
amycin than the drug-sensitive P388/4 cells (6). Resistant clone
3 and clone 7 cells were cross-resistant to all compounds studied
with the exception of melphalan and the relative resistance
profile was actinomycin D > daunorubicin = mitoxantrone =
colchicine > etoposide. Although clone 7 cells were twofold
more resistant to ADR than clone 3 cells, the level of cross-
resistance between clone 3 and 7 cells towards the other agents
studied appeared less marked.
Time Course of Repair of DNA Double-Strand Breaks Induced
by Adriani vein in Adriamycin-sensitive and -resistant P388 Leu
kemic Cells. DNA double-strand breaks induced in ADR-sen
sitive and -resistant P388 cells by treatment with ADR for l h
were determined by the neutral elution procedure of Kohn (20).
Evidence of repair of DNA double-strand breaks was observed
in all three cell lines as shown in a time course of DSB extending
24 h after removal of drug (Fig. 1). A split-plot analysis of
variance was calculated for the data and least squares means
comparisons were made between the peak values of DNA
damage and DSB remaining at 24 h: these differences were
highly significant for all three cell lines (p = 0.0016 for sensitive
cells, p = 0.0035 for resistant clone 3 cells, and p = 0.0001 for
clone 7). Furthermore, onset of DNA repair and/or reversal of
DNA damage in drug-resistant cells (clones 3 and 7) was
apparent l h after removal of drug, whereas in sensitive cells
Table 1 Cross-resistance patterns of cloned P388 leukemic cells to various
antitumor agents
DrugAdriamycin
Daunorubicin
Actinomycin D
Mitoxantrone
Etoposide
Colchicine
Melphalan/>â€ž
for sensi
tive P388/4
cells0(nM)33
Â±5
9Â± 1
13Â±1
168 Â±4
601 Â±107
152 Â±4
684 Â±57Relative
resistance'P388/ADR/35*
11'
18e
13'4'Nry1.1'P388/ADR/710e
16e
18e
11'
6e
12*
Uf
Â°A, values, derived from dose-survival curves of sensitive P388/4 leukemic
cells and resistant P388/ADR/3 and P388/ADR/7 cells following treatment with
appropriate drug for l h at 37'C, as described in the text. Each value is a mean
of at least two experiments, Â±SE.
* Relative resistance is the ratio of A, for resistant cells treated with a particular
drug to the /,'â€žfor sensitive cells treated with the same agent. A series of t tests
were performed comparing the significance of the difference in slopes of the dose
survival curves of drug-sensitive and -resistant cells.
'P< 0.001.
J ND, not determined.
'p<0.01.
'Not significant.
24
Fig. 1. Time course of repair of DNA double-strand breaks induced by
Adriamycin in P388 leukemia cells. Cells were treated with Adriamycin for l h
at a concentration of 0.2 Â¡Mfor sensitive P388/4 cells (O), at 0.35 MMfor clone
3 cells (â€¢)and 0.5 MMfor clone 7 cells (D). The number of double-strand breaks,
expressed as rad-equivalents (dose of radiation producing an equivalent number
of breaks), is plotted against time after removal of drug. Curves, mean of five
experiments; bars, SE; inset, time course of repair of DNA double-strand breaks
of the same data from peak DNA damage induced in the resistant clones onward,
plotted as a double-log relationship. The linear regression equation for the double
log plot for sensitive P388/4 cells was log.y = -0.7881 -logÂ«.t+ 8.464 with a
correlation coefficient of -0.9659, that for resistant P388/ADR/3 cells was log.
y = 0.6132log. x + 7.344 with a correlation coefficient of -0.9845, and that for
resistant P388/ADR/7 cells was \og.y = 0.7701 log.* + 7.071 with a correlation
coefficient of 0.9889.
this did not occur until 4 h. The time course of repair of DNA
DSB from peak damage onward was plotted as a double-log
relationship (Fig. 1, inset). Analysis of covariance comparing
the intercepts of these curves, which is an index of the time of
onset of repair, showed that there was a significant difference
between the sensitive cells and either clone 3 cells (p = 0.0154)
or clone 7 cells (p = 0.0009), but there was no significant
difference between the two resistant cell lines. Once the repair
process was initiated, the rates of repair, as reflected by the
slopes of the repair curves, showed no significant difference
between the three cell lines as determined by analysis of co var
iance (Fig. 1, inset).
Glutathione Transferase Activity in Adriamycin-sensitive and
-resistant P388 Leukemia Cells. The level of glutathione trans-
ferase activity was determined in whole cell extracts of ADR-
sensitive and -resistant cells. Enzyme activity (mean Â±SE) in
sensitive P388/4 cells was 9.49 Â±1.00 nmol/min/mg protein,
that in resistant clone 3 cells was 13.36 Â±1.03 nmol/min/mg
protein, and that in clone 7 cells was 13.96 Â±1.44 nmol/min/
mg protein. Thus the level of glutathione transferase activity
was 1.44-fold greater in resistant cells compared to sensitive
cells and this difference was statistically significant (p = 0.01).
Furthermore, a radiolabeled anionic glutathione transferase
cDNA probe demonstrated on Northern blot analysis an in
creased level of GST mRNA in the resistant cells (Fig. 2). This
cDNA probe was cloned from human lung tissue (38), and is
identical except for guani ne at position 313 and thymine at 341
to the cDNA for human placental GST* recently reported by
Kano et al. (39). However, no changes were detected in the
genomic DNA by Southern analysis (data not shown). Densi-
tometric analysis of the Northern blot indicated a progressive
increase in mRNA in resistant cells reaching 1.9-fold in clone
7 cells, with reference to signals obtained by hybridization of a
similar blot with a control /8-actin probe. Western blot analysis
with a polyclonal antibody prepared against anionic GSIV from
human mesothelioma (40), demonstrated a proportionate in-
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Fig. 2. Northern blot analysis of GST. A, RNA blot hybridization with a MP-
labeled GSTV cDNA fragment showing the relative expression of anionic gluta-
thione transferase. Lane 1, drug sensitive P388/4 cells; lane 2, drug-resistant
P388/ADR/3 cells; lane 3, drug-resistant P388/ADR/7 cells. Hybridization and
electrophoresis conditions are described in the text. R. blot hybridized with a ÃŸ-
actin probe.
-45
-14
Fig. 3. Western blot analysis showing the relative level of anionic GST in drug
sensitive and resistant P388 leukemia cells. Each lane was loaded with 100 Â«Â¿gof
cytosolic protein; details of separation and blotting are described in the text. Lane
1, sensitive P388/4 cells; lane 2, drug-resistant P388/ADR/3 cells; lane 3, drug-
resistant P388/ADR/7 cells. Positions of molecular weight markers (M, x id')
are indicated on the right.
crease of a protein band with a molecular weight of about
25,000 in the resistant lines (Fig. 3). A control experiment with
preimmune antisera detected no comparable band. Parallel
studies with cDNA probes for cationic GST isozymes from rat
liver provided by Dr. C. B. Pickett and a polyclonal anti-rat
liver GST antibody from Dr. K. Tew were negative (data not
shown).
Thus, the enzyme activity data and the findings by Northern
and Western blot analysis indicate that although the changes
are small, taken together the results are consistent with altera
tion of anionic but not cationic GST in resistant cells.
Time Course of Adriamycin Efflux. A time course of efflux of[14C]ADR from P388 cells is shown in Fig. 4. Drug efflux was
relatively rapid for 3 to S min, thereafter reaching a plateau
level at 30 min with approximately 45 to 60% of the initial
radioactivity remaining in the cells. A semilogarithmic plot of
0 10 20
TIME (min)
Fig. 4. Efflux of (MC)Adriamycin from P388 leukemia cells. Cells were prein-
cubated for 10 min with ADR at a concentration of 0.1 JIMfor P388/4 cells (O),
0.15 iiM for clone 3 cells (â€¢),and 2.0 /iM for clone 7 cells (D). The intracci lu lar
drug level (mean Â±SE) at the onset of efflux was 2.9 Â±0.6 attorno! in sensitive
cells, 4.3 Â±0.5 attomol in clone 3 cells, and 5.0 Â±1.7 attorno! in clone 7 cells.
The cells were washed through a layer of SF120 oil to remove extracellular drug,
resuspended in drug-free transport medium at 37'C, and efflux measured as
indicated. The intracellular drug concentration was determined and the data
expressed as a percentage of initial intracellular drug concentration plotted against
efflux time. Points, mean of at least four experiments. Inset, decay time analysis
of drug efflux over the first 5 min presented as a semilogarithmic plot of
exchangeable intracellular Adriamycin concentration (expressed as a percentage
of the initial exchangeable intracellular drug level) plotted against efflux time.
The exchangeable intracellular drug concentration was obtained by subtracting
nonexchangeable drug from total intracellular Adriamycin; nonexchangeable drug
was derived from the plateau region of the time course of drug efflux. The linear
regression equation of the plot for drug efflux from sensitive P388/4 cells was
lo&vV= -0.00345* + 4.6022 with a correlation coefficient of -0.9480; that for
P388/ADR/3 cells was logÂ«y = -0.0035U + 4.5621, with a correlation coeffi
cient of -0.9480; and for P388/ADR/7 cells logÂ«y = -0.00350* + 4.6110, with
a correlation coefficient of -0.9853.
exchangeable intracellular ADR against time over the first 5
min of efflux was linear, suggesting that initial drug efflux
followed first-order kinetics (Fig. 4, inset). The slope of the
linear regression equation for drug efflux was used to calculate
the TV,for efflux, which was virtually identical for all 3 cell
lines; the T.. was 3.35 min in sensitive cells, 3.29 min in clone
3 cells and 3.30 min in clone 7 cells.
Sodium azide and 2,4-dinitrophenol are metabolic inhibitors
which have been shown to inhibit the active extrusion of ADR
especially in drug-resistant cells (3, 5). A time course of [I4C]
ADR uptake by P388 leukemia cells in the presence or absence
of sodium azide or 2,4-dinitrophenol showed that these drugs
did not augment uptake of ADR as would be expected in the
presence of an active efflux pump (Fig. 5). On the contrary,
sodium azide or 2,4-dinitrophenol actually diminished uptake
of [14C]ADR. The finding of an identical efflux rate constant in
drug-sensitive and -resistant cells, together with the failure of
metabolic inhibitors to augment ADR uptake strongly suggest
that an active extrusion pump was not operational in these
cells.
Enhanced Expression of P-Glycoprotein in Adriamycin-resist-
ant Cells. The cDNA clone pCHPl, encoding a 640-base pair
fragment of the M, 170,000 P-glycoprotein, was recently iso
lated from a cDNA library of a colchicine-resistant CHO cell
line (15). The pCHPl insert was used to determine the relative
expression of P-glycoprotein in P388 leukemia cells selected
against ADR. Northern blot analysis demonstrated that the
probe hybridized to a single mRNA species of 4.7 kilobases,
which was relatively enhanced in the resistant lines (Fig. 6/1).
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Fig. 5. Time course of uptake of ['4C)Adriamycin by drug-sensitive P388/4
cells (A and D), drug-resistant P388/ADR/3 cells (B and Â£),and P388/ADR/7
cells (C and /â€¢')suspended in Dulbecco's phosphate buffered saline at 37*C in the
presence of 10 HIM glucose (O) or either 1 HIM sodium azide or 1 HIM 2,4-
dinitrophenol (â€¢).Concentration of ("CjAdriamycin used was either 0.2 J/Mfor
experiments with sodium azide (.(-<) or 2 Â«Mfor experiments with 2.4 diniim
phenol (D-F). Approximately 2-4 x 10* cells/ml were incubated with drugs,
aliquots of cell suspension were removed at the times indicated and radioactivity
was determined by methods described in the text.
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Fig. 6. Northern blot analysis of P-glycoprotein. . I. RNA analysis showing
the relative expression of P-glycoprotein in drug sensitive parental P388 cells and
multidrug resistant sublines designated as clone 3 and clone 7. Five /Â¿gof each
mRNA preparation was electrophoresed in a 1% formaldehyde-agarose gel,
transferred onto nitrocellulose and hybridized to pCHPl, a 640-base pair cDNA
fragment of P-glycoprotein, as described in "Materials and Methods." B, As a
control, the Iirst probe was removed by washing in a heated solution of 0.1 x
SSC, 0.1% SDS and the same blot was reprobed with "P-labeled rat 0-actin
cDNA.
Densitometric scanning of the 4.7-kilobase transcripts, showed
an increment of approximately 1.8-fold in clone 3 cells and 2.0-
fold in clone 7 cells. By contrast, there was no significant
difference in the level of the 2-kilobase /3-actin mRNA in the
three cell lines (Fig. 6B). Using the C219 monoclonal antibody
(15), a definite increase in P-glycoprotein level was also detected
by Western blot analysis (Fig. 7). The slight difference in
molecular weight of P-glycoprotein in resistant cells from that
of the positive control represents species variation between
mouse and Chinese hamster cells.
To determine if the over expression of P-glycoprotein was
due to an increase in gene copy number, DNA from all three
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Fig. 7. Western blot analysis of membrane proteins showing increased expres
sions of P-glycoprotein in drug resistant cell lines. Each lane was loaded with SO
(ig of membrane protein; details of separation and blotting are described in the
text. A plasma membrane protein-enriched preparation was isolated from sensi
tive P388/4 cells (lane I); drug-resistant P388/ADR/3 cells (lane 2); P388/ADR/
7 cells (lane 3); Aux B, CHO hamster cells (lane 4); and CHRC5 drug-resistant
CHO cells (lane 5), serving as a positive control.
cell lines and DNA derived from the spleen of DBA/2 mice
was digested with EcoRl, Hindlll, or Pstl (Fig. 8). The South
ern blots of the digestion mixture yielded the same banding
pattern and hybridization intensity in all cases, suggesting that
neither gene amplification nor rearrangement had occurred.
DISCUSSION
Biochemical and pharmacological evidence indicates that
resistance to ADR in the cloned lines of Adriamycin-sensitive
and -resistant P388 leukemia cells is mull Â¡factorial.In an earlier
study, it was shown that resistance to Adriamycin in these cells
could be attributed to reduced levels of DNA single- and double-
strand breaks induced by the drug in resistant cells; the cytotoxic
activity of ADR appeared to correlate more closely with for
mation of DNA double-strand breaks than with single-strand
breaks (6).
As a result of this relationship, we compared the time course
of repair of DNA double-strand breaks induced by ADR in the
drug-sensitive and -resistant cell lines in order to assess the role
of DNA repair in the development of drug resistance. The drug-
resistant clones 3 and 7 appeared to display an earlier onset of
DNA repair compared to drug-sensitive cells (Fig. 1). An alter
nate interpretation is that DNA damage was more prolonged
in sensitive cells and that altered drug accumulation, distribu
tion and/or retention in resistant compared to sensitive cells
might account for these findings. This study does not provide
a clear choice between these two possibilities, however, we favor
the first explanation since extracellular drug concentrations
were selected to give comparable cell kill and intracellular drug
levels in sensitive and resistant cells (6). Although evidence of
repair was earlier in resistant cells, once underway the rate of
repair of DNA double-strand breaks was similar in both sensi
tive and resistant cells. This process whereby resistant cells
display an early onset of DNA repair without an increase in the
actual rate of repair has also been proposed to account for
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Fig. 8. Southern blot analysis of genomic DNA derived from normal DBA/2
mice, parental sensitive P388 cells, drug resistant clone 3 and clone 7 cells.
Genetic DNA (10 pg) was digested to completion with EcoRl, Hindlll, or Pstl,
transferred onto nitrocellulose and hybridized to pCHPl. The DNA size markers
are //im/III-digestcd X-DNA.
resistance to cw-DDP in LI210 cells (41). Other investigators,
using other drugs and cell culture systems, have demonstrated
a correlation between the ability to repair drug-induced DNA
damage and relative drug sensitivity (41-45).
An additional finding that supports the multifactorial nature
of resistance to ADR in these cloned P388 leukemia cells is
that the level of GST enzyme activity was elevated approxi
mately 50% in drug-resistant cells compared to sensitive cells.
Northern and Western analysis show a concomitant increase in
mRNA and protein levels of an anionic GST (Fig. 2 and 3);
however, we found no such alterations for cationic isozymes
(data not shown). Earlier reports indicated a similar overexpres-
sion of an anionic GST, without gene amplification, in a MCF-
7 cell line 200-fold resistant to ADR (7). GST is a family of
enzymes that can detoxify a wide spectrum of xenobiotics via
conjugation with glutathione or by reduction of organic perox
ides to less reactive alcohols (7,8,46-48). The latter mechanism
has been suggested to play an important role in the development
of resistance to ADR (7). The finding of no alteration of cationic
GST together with no cross resistance to melphalan is consist
ent with a previous report implicating cationic GST in resist
ance to alkylating agents (8).
Efflux of ADR as measured by the efflux rate constant was
identical in sensitive and resistant clone 3 and clone 7 cells
(Fig. 4). Furthermore, the metabolic inhibitors azide and dini-
trophenol did not augment uptake of ADR in either sensitive
or resistant cells (Fig. 5). These findings suggest that an active
extrusion pump was not operational in these cells, in contrast
to other ADR-resistant cell lines, in which an energy-dependent
active drug efflux system has been demonstrated (1-5).
Resistance to ADR in the cloned P388 leukemic cells is also
associated with multidrug resistance (MDR) or pleiotropic drug
resistance. Cross-resistance is noted towards a variety of other
cytotoxic drugs with the notable exception of melphalan (Table
1), a finding n ted by others (49, 50). Some of the drugs used
in the study of cross-resistance are chemically unrelated to
ADR, the drug which was originally used to select the resistant
lines. In addition, the level of resistance to actinomycin D and
mitoxantrone is higher than that observed for ADR itself,
indicating as others have reported that in MDR, the cells need
not be most resistant to the primary agent used (16, 51-53).
Pleiotropic resistance to unrelated drugs has been strongly
correlated with the presence of P-glycoprotein, a plasma mem
brane protein of M, 170,000 (11, 12, 15, 54, 55). A 640-base
pair cDNA clone, pCHPl, was recently used to demonstrate P-
glycoprotein overexpression due to gene amplification in CHO
lines resistant to colchicine (15). There is considerable evidence
for gene amplification leading to enhanced P-glycoprotein
expression in cells resistant to various drugs (14-17, 56-58);
however, although increase in gene copy number seems to be
commonly associated with altered expression for cells cultured
in vitro, this may not hold true in vivo, where low level of drug
exposure is encountered. Here, we report a transcriptionally
upregulated model in cloned P388 leukemia cells selected with
ADR. We have shown that a 1.8- and 2-fold increment in P-
glycoprotein mRNA levels in clone 3 and 7 cell lines, respec
tively (Fig. 6), is not the result of gene amplification or re
arrangement (Fig. 8). The lack of difference in ÃŸ-actingene
expression in the sensitive and resistant cell lines suggests that
comparable levels of RNA were loaded on the gels (Fig. 6).
Moreover, Western analysis with a monoclonal antibody
showed a distinct increase in the P-glycoprotein levels in the
resistant cells (Fig. 7). Therefore, it would be reasonable to
suggest that control of P-glycoprotein gene expression may be
exerted by increasing the rate of transcription, message stability,
or other posttranscriptional events necessary for maturation
and delivery of the RNA to the cytoplasm (59, 60).
It has been shown that P-glycoprotein exhibits sequence
homology to bacterial he mo lysin export protein (17). In the
cloned P388 leukemia cells, although enhanced transcription
and translation of P-glycoprotein was detected, no pharmaco
logical evidence of increased pump activity was found. There
are at least two possible explanations of this apparent paradox:
firstly, the level of P-glycoprotein in these cells may be inade
quate to result in measurable pump activity, or secondly, P-
glycoprotein may serve in a nontransport fashion to protect
cells from low levels of toxic lipophilic compounds; presumably
in resistant cells this basic function is augmented as suggested
by Gerlach et al. (17). If P-glycoprotein acts as a pore form ing
protein, the pump activity, at least in these cells, may be a
relatively late contributor to multifactorial drug resistance. In
cells with a higher level of resistance and more dramatic alter
ation of P-glycoprotein expression, functional evidence of an
active extrusion pump might be expected to appear, as reported
for other cell lines (1-5).
In the cloned ADR-resistant cells studied here with a rela
tively modest 5- to 10-fold increase in resistance, pump activity
was not evident. A great deal of interest has been directed at P-
glycoprotein, however, increased P-glycoprotein is but one of
several changes that comprise multifactorial drug resistance,
and indeed in some resistant cells enhanced expression of P-
glycoprotein does not occur (53). Decreased drug uptake, de
creased formation of DNA single- and double-strand breaks,
increased GST activity, earlier onset of DNA repair, as well as
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elevated P-glycoprotein are all characteristic of multifactorial
drug resistance in these cells.
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